Eledon Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid
Eledon Pharmaceuticals, Inc. (ELDN) had Lessee, Operating Lease, Liability, to be Paid of $497.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid $497.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid $597.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $697.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid $795.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2026-06-30 | $497.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $597.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $697.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $795.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $893.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $990.00K 10-Q/A · filed 2025-08-14 |
| 2024-12-31 | $1.09M 10-K/A · filed 2025-08-14 |
| 2024-09-30 | $571.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $673.00K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $287.00K 10-Q/A · filed 2024-08-19 |
| 2023-12-31 | $388.00K 10-K/A · filed 2024-08-19 |
| 2023-09-30 | $487.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $585.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $683.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $766.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $864.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $606.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $703.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $799.00K 10-K · filed 2022-03-24 |
| 2021-09-30 | $226.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $275.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $97.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $146.00K 10-K · filed 2021-03-31 |
| 2020-09-30 | $195.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $241.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $288.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $334.00K 10-K · filed 2020-03-17 |
| 2019-09-30 | $381.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $425.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $470.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |